| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |